Discover Comprehensive Insights with the Clinical Laboratory Services Report
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies poised to earn the most revenue and examines their strategies post-COVID-19 as the virus becomes endemic.
Why This Report is Essential for IVD Manufacturers
The annual review of the clinical labs market is a must-have resource for IVD manufacturers. Clinical laboratories are fundamental to the diagnostic services within the IVD market, providing critical analysis for a myriad of disorders and diseases, including pathology, immunology, cholesterol testing, allergy testing, urinalysis, and genetic testing. These laboratories are indispensable to the healthcare industry.
Market Opportunity in Lab Services: Now in its 9th Edition
The Worldwide Market for Clinical Laboratory Services, 9th Edition offers a detailed overview of the clinical laboratory industry, highlighting key trends and growth drivers.
Key Features of the Report
- Industry Overview: Gain a comprehensive understanding of the clinical laboratory industry and the trends propelling its growth.
- Influential Statistics: Examine data on disease incidence in the U.S. and globally, demographic trends, life expectancy, and company strategies.
- Global Focus: The report covers key regions including:
- North America (United States, Canada)
- Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
- Asia Pacific (Japan, China, India, South Korea, Australia)
- Latin America (Brazil, Mexico)
Specialty Segments Covered
- Essential and Routine Testing: Clinical chemistry, hematology, coagulation, endocrinology
- Immunology and Microbiology Testing
- Cytology and Histology Testing
- Genetic Testing
- Toxicology Testing: Drugs of abuse
- COVID-19
Market Segmentation by Laboratory Type
- Independent and Reference Laboratories
- Hospital-based Laboratories
- Clinic-based Laboratories
Competitive Analysis
The report provides a thorough competitive analysis of leading clinical laboratory providers, offering insights into market positioning and strategic initiatives.
Data and Forecasting
- Market Data: Pertains to the world market at the manufacturers’ level.
- Base Year: 2023
- Historical Data: 2018 through 2022
- Forecast Data: 2024 through 2028
- CAGRs: Provided for the 2023-2028 period for each segment.
Challenges and Adjustments
This report is part of a regularly updated series. Each new edition reflects the latest findings, adjusting for company performance, pricing pressures, reimbursement challenges, and the ongoing impacts of COVID-19.
Exclusions
The market analysis excludes revenues from clinical trial laboratory testing, environmental testing, veterinary laboratory testing, and other similar industries.
Prepare for Future Market Trends
Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers and acquisitions, and national expansions. This report is a critical tool for navigating the evolving clinical laboratory market landscape.
Table of Contents
Samples
LOADING...
Companies Mentioned
- Abbott Laboratories
- ARUP Labs
- BioReference Laboratories, Inc.
- DaVita, Inc.
- Eurofins Scientific
- Exact Sciences Corp.
- H.U. Group Holdings
- Laboratory Corporation of America - Labcorp
- Medicover AB
- Myriad Genetics
- NeoGenomics
- Quest Diagnostics
- Siemens Healthineers
- Sonic Healthcare
- Spectra Laboratories (Fresenius)
- SYNLAB - Labco Group
- Unilabs